Cargando…
Intestinal barrier dysfunction plays an integral role in arthritis pathology and can be targeted to ameliorate disease
BACKGROUND: Evidence suggests an important role for gut-microbiota dysbiosis in the development of rheumatoid arthritis (RA). The link between changes in gut bacteria and the development of joint inflammation is missing. Here, we address whether there are changes to the gut environment and how they...
Autores principales: | Matei, Diana E., Menon, Madhvi, Alber, Dagmar G., Smith, Andrew M., Nedjat-Shokouhi, Bahman, Fasano, Alessio, Magill, Laura, Duhlin, Amanda, Bitoun, Samuel, Gleizes, Aude, Hacein-Bey-Abina, Salima, Manson, Jessica J., Rosser, Elizabeth C., Klein, Nigel, Blair, Paul A., Mauri, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280953/ https://www.ncbi.nlm.nih.gov/pubmed/34296202 http://dx.doi.org/10.1016/j.medj.2021.04.013 |
Ejemplares similares
-
Anti-RNP positivity in primary Sjögren’s syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement
por: Abbara, Salam, et al.
Publicado: (2019) -
Validation Study of a New Random-Access Chemiluminescence Immunoassay Analyzer i-TRACK10(®) to Monitor Infliximab and Adalimumab Serum trough Levels and Anti-Drug Antibodies
por: Berger, Anne Emmanuelle, et al.
Publicado: (2022) -
Gene therapy for severe combined immunodeficiencies and beyond
por: Fischer, Alain, et al.
Publicado: (2019) -
Low Percentage of Signal Regulatory Protein α/β(+) Memory B Cells in Blood Predicts Development of Anti-drug Antibodies (ADA) in Adalimumab-Treated Rheumatoid Arthritis Patients
por: Magill, Laura, et al.
Publicado: (2018) -
Articular manifestations in patients with inflammatory bowel diseases treated with anti-TNF
por: Cachen, Laurie, et al.
Publicado: (2022)